Leukine Related Clinical Trials
Randomized Phase 2 Trial of Pre-Chemotherapy Leukine Vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [Withdrawn]
Study of the Safety & Efficacy of GM-CSF (Leukine) in the Treatment of Alzheimer's Disease [Recruiting]
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Recruiting]
A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis [Not yet recruiting]
GM-CSF in Treating Patients With Relapsed Prostate Cancer [Not yet recruiting]
GM-CSF as Adjuvant Therapy of Melanoma [Completed]
Vaccine Therapy in Treating Patients With Breast Cancer [Recruiting]
GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere [Recruiting]
Does GM-CSF Restore Neutrophil Phagocytosis in Critical Illness? [Not yet recruiting]
Randomized Phase III Trial of Leukine® Vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer [Terminated]
Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF [Recruiting]
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Recruiting]
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Recruiting]
Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma [Recruiting]
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Recruiting]
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Mobilization of Progenitor Cells in Peripheral Arterial Disease [Recruiting]
Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma [Recruiting]
GM-CSF for Immunomodulation Following Trauma (GIFT) Study [Recruiting]
Open-Label Trial of LEUKINE® in Active Crohn's Disease [Completed]
Ipilimumab and GMCSF Immunotherapy for Prostate Cancer [Not yet recruiting]
PROgenitor Cell Release Plus Exercise to Improve functionaL Performance in PAD: The PROPEL Study [Recruiting]
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF [Recruiting]
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Patients With Stage II-IV HER2-Positive Breast Cancer [Recruiting]
Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma [Recruiting]
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-Cleaved Lymphoma [Completed]
Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) [Recruiting]
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation [Recruiting]
Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn’s Disease Who Have Previously Responded to Treatment With Sargramostim [Completed]
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity [Active, not recruiting]
A Phase II Study of 5-Azacitadine and Sargramostim as Maintenance Treatmetn After Definitive Therapy for Poor-risk AML or MDS [Not yet recruiting]
Open-Label of LEUKINE® in Active Crohn's Disease [Terminated]
A Phase II Trial of Docetaxel/Prednisone in Combination With Sargramostim as Treatment for Hormone-Refractory Prostate Cancer [Active, not recruiting]
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma [Recruiting]
GM-CSF in Patients With Pulmonary Alveolar Proteinosis [Recruiting]
High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow [Recruiting]
High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma [Recruiting]
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC [Recruiting]
Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [Active, not recruiting]
Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma [Recruiting]
Study of Sargramostim in Moderately to Severely Active Crohn’s Disease [Terminated]
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia [Recruiting]
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma [Not yet recruiting]
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma [Not yet recruiting]
Phase II Trial of Rituximab Plus Sargramostim for Newly Diagnosed Follicular B-Cell Lymphoma in Adults [Recruiting]
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery [Active, not recruiting]
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Patients With Advanced Solid Tumors [Recruiting]
Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA) [Active, not recruiting]
Fludarabine, Cyclophosphamide, and Rituximab (FCR) Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia [Recruiting]
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia [Completed]
Docetaxel Followed By GM-CSF in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Recruiting]
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer [Completed]
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma [Recruiting]
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [Completed]
Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Completed]
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers [Completed]
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma [Recruiting]
Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [Active, not recruiting]
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab [Recruiting]
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer [Recruiting]
Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma [Active, not recruiting]
A Safety/Tolerability and Pharmakokinetic Study of Sargramostim Administrated in the Gingiva [Recruiting]
A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients [Recruiting]
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [Completed]
Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-Cell Lymphoma, a Form of Non-Hodgkin's Lymphoma [Recruiting]
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Suspended]
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia [Active, not recruiting]
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [Active, not recruiting]
Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Active, not recruiting]
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy [Completed]
Efficacy Study of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF [Recruiting]
An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [Completed]
Vaccine Therapy With or Without Sargramostim in Treating Patients With Metastatic Prostate Cancer [Recruiting]
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma [Completed]
A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia [Completed]
A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine [Completed]
Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and Peginterferon Alfa-2b [PEG-INTRON(R)] [Recruiting]
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
GM-CSF in Women With Recurrent Ovary Cancer [Recruiting]
Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis [Completed]
PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer [Active, not recruiting]
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma [Completed]
Rituximab, Autologous Vaccine Therapy, and Sargramostim in Treating Patients With Recurrent or Refractory Follicular B-Cell Lymphoma
Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Active, not recruiting]
Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone OR Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab Followed by Vaccine Therapy Plus Sargramostim in Treating Patients With Stage II, Stage III, or Stage IV Follicular Lymphoma [Recruiting]
A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility [Completed]
Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung [Active, not recruiting]
Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC [Completed]
Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [No longer recruiting]
Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma [Recruiting]
Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment [No longer recruiting]
Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer [Recruiting]
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus [Completed]
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Completed]
|
